Table 4.
Clinical setting | CFR |
HCM pediatric pts (septum) [29] | 0.84 ± 0.33 |
Control | 2.94 ± 0.35 |
Aortic insufficiency [30] | 1,67 ± 0,4 |
Control | 4,03 ± 0,52 |
Dilated cardiomyopathy [31] | 2.2 ± 0.8 |
Control | 3.3 ± 0.8 |
Dilated cardiomyopathy [32] | 2,0 ± 0,6 |
NYHA class I | 2,43 ± 0,4 |
NYHA class II | 2,21 ± 0,2 |
NYHA class III | 1,98 ± 0,3 |
NYHA class IV | 1,78 ± 0,3 |
Control | 3,2 ± 0,5 |
Diabetes [33] | |
Without retinopathy | 2.8 ± 0.3 |
with early diabetic retinopathy | 2.3 ± 0.3 |
with slightly advanced retinopathy | 1.6 ± 0,2 |
Control | 3.3 ± 0,4 |
Patients with chest pain and [34] | |
Without ST depression in ECG exercise test | 3.0 ± 0.6 |
With up-slope ST depression in ECG exercise test | 3.1 ± 0.6 |
With flat ST depression in ECG exercise test | 2.1 ± 0.6 |
With down-slope ST depression ECG exercise test | 2.0 ± 0,4 |
Hypertension [35] | |
Concentric remodeling | 2.0 ± 0.7 |
Concentric hypertrophy | 2.3 ± 0.8 |
Eccentric hypertrophy | 2.9 ± 0.6 |
Normal geometry | 2.7 ± 0.4 |
Control | 4.2 ± 0.5 |